Basic fibroblast growth factor (bFGF) enhances tissue sparing and functional recovery following moderate spinal cord injury

Alexander G. Rabchevsky, Isabella Fugaccia, Anita Fletcher-Turner, Deborah A. Blades, Mark P. Mattson, Stephen W. Scheff

Research output: Contribution to journalArticle

Abstract

The rapid increase in basic fibroblast growth factor (bFGF) production following spinal cord injury (SCI) in rats is thought to serve a role in the cellular processes responsible for the functional recovery often observed. In this study, bFGF was intrathecally administered continuously for I week beginning 30 min after a moderate (12.5 mm) spinal cord contusion in adult rats using the New York University impactor device. Osmotic minipumps were implanted into the lateral ventricle and lumbar thecal sac to deliver bFGF at a rate of 3 μg or 6 μg per day versus control vehicle. Animals were behaviorally tested for 6 weeks using the Basso, Beattie, Bresnahan locomotor rating scale and histologically assessed for both tissue sparing and glial reactivity rostral and caudal to the lesion. Rats treated with bFGF regained coordinated hindlimb movements earlier than controls and demonstrated consistent coordination from 4 to 6 weeks. Vehicle-treated rats showed only modest improvements in hindlimb function. The amount of spared tissue was significantly higher in bFGF-treated rats than in controls. Astrocyte and microglial reactivity was more pronounced in bFGF-treated animals versus controls. In summary, intrathecal infusion of exogenous bFGF following SCI significantly reduces tissue damage and enhances functional recovery. Early pharmacological intervention with bFGF following SCI may serve a neuroprotective role and/or create a proregenerative environment, possibly by modulating the neuroglial response.

Original languageEnglish (US)
Pages (from-to)817-830
Number of pages14
JournalJournal of Neurotrauma
Volume16
Issue number9
StatePublished - Sep 1999
Externally publishedYes

Fingerprint

Fibroblast Growth Factor 2
Spinal Cord Injuries
Hindlimb
Lateral Ventricles
Neuroglia
Astrocytes
Pharmacology
Equipment and Supplies

Keywords

  • Astrocytes
  • Behavior
  • GFAP
  • Microglia
  • OX-42
  • Tissue sparing
  • White matter

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Rabchevsky, A. G., Fugaccia, I., Fletcher-Turner, A., Blades, D. A., Mattson, M. P., & Scheff, S. W. (1999). Basic fibroblast growth factor (bFGF) enhances tissue sparing and functional recovery following moderate spinal cord injury. Journal of Neurotrauma, 16(9), 817-830.

Basic fibroblast growth factor (bFGF) enhances tissue sparing and functional recovery following moderate spinal cord injury. / Rabchevsky, Alexander G.; Fugaccia, Isabella; Fletcher-Turner, Anita; Blades, Deborah A.; Mattson, Mark P.; Scheff, Stephen W.

In: Journal of Neurotrauma, Vol. 16, No. 9, 09.1999, p. 817-830.

Research output: Contribution to journalArticle

Rabchevsky, AG, Fugaccia, I, Fletcher-Turner, A, Blades, DA, Mattson, MP & Scheff, SW 1999, 'Basic fibroblast growth factor (bFGF) enhances tissue sparing and functional recovery following moderate spinal cord injury', Journal of Neurotrauma, vol. 16, no. 9, pp. 817-830.
Rabchevsky AG, Fugaccia I, Fletcher-Turner A, Blades DA, Mattson MP, Scheff SW. Basic fibroblast growth factor (bFGF) enhances tissue sparing and functional recovery following moderate spinal cord injury. Journal of Neurotrauma. 1999 Sep;16(9):817-830.
Rabchevsky, Alexander G. ; Fugaccia, Isabella ; Fletcher-Turner, Anita ; Blades, Deborah A. ; Mattson, Mark P. ; Scheff, Stephen W. / Basic fibroblast growth factor (bFGF) enhances tissue sparing and functional recovery following moderate spinal cord injury. In: Journal of Neurotrauma. 1999 ; Vol. 16, No. 9. pp. 817-830.
@article{35eb5f45ab63454da5d16135dc3d46be,
title = "Basic fibroblast growth factor (bFGF) enhances tissue sparing and functional recovery following moderate spinal cord injury",
abstract = "The rapid increase in basic fibroblast growth factor (bFGF) production following spinal cord injury (SCI) in rats is thought to serve a role in the cellular processes responsible for the functional recovery often observed. In this study, bFGF was intrathecally administered continuously for I week beginning 30 min after a moderate (12.5 mm) spinal cord contusion in adult rats using the New York University impactor device. Osmotic minipumps were implanted into the lateral ventricle and lumbar thecal sac to deliver bFGF at a rate of 3 μg or 6 μg per day versus control vehicle. Animals were behaviorally tested for 6 weeks using the Basso, Beattie, Bresnahan locomotor rating scale and histologically assessed for both tissue sparing and glial reactivity rostral and caudal to the lesion. Rats treated with bFGF regained coordinated hindlimb movements earlier than controls and demonstrated consistent coordination from 4 to 6 weeks. Vehicle-treated rats showed only modest improvements in hindlimb function. The amount of spared tissue was significantly higher in bFGF-treated rats than in controls. Astrocyte and microglial reactivity was more pronounced in bFGF-treated animals versus controls. In summary, intrathecal infusion of exogenous bFGF following SCI significantly reduces tissue damage and enhances functional recovery. Early pharmacological intervention with bFGF following SCI may serve a neuroprotective role and/or create a proregenerative environment, possibly by modulating the neuroglial response.",
keywords = "Astrocytes, Behavior, GFAP, Microglia, OX-42, Tissue sparing, White matter",
author = "Rabchevsky, {Alexander G.} and Isabella Fugaccia and Anita Fletcher-Turner and Blades, {Deborah A.} and Mattson, {Mark P.} and Scheff, {Stephen W.}",
year = "1999",
month = "9",
language = "English (US)",
volume = "16",
pages = "817--830",
journal = "Journal of Neurotrauma",
issn = "0897-7151",
publisher = "Mary Ann Liebert Inc.",
number = "9",

}

TY - JOUR

T1 - Basic fibroblast growth factor (bFGF) enhances tissue sparing and functional recovery following moderate spinal cord injury

AU - Rabchevsky, Alexander G.

AU - Fugaccia, Isabella

AU - Fletcher-Turner, Anita

AU - Blades, Deborah A.

AU - Mattson, Mark P.

AU - Scheff, Stephen W.

PY - 1999/9

Y1 - 1999/9

N2 - The rapid increase in basic fibroblast growth factor (bFGF) production following spinal cord injury (SCI) in rats is thought to serve a role in the cellular processes responsible for the functional recovery often observed. In this study, bFGF was intrathecally administered continuously for I week beginning 30 min after a moderate (12.5 mm) spinal cord contusion in adult rats using the New York University impactor device. Osmotic minipumps were implanted into the lateral ventricle and lumbar thecal sac to deliver bFGF at a rate of 3 μg or 6 μg per day versus control vehicle. Animals were behaviorally tested for 6 weeks using the Basso, Beattie, Bresnahan locomotor rating scale and histologically assessed for both tissue sparing and glial reactivity rostral and caudal to the lesion. Rats treated with bFGF regained coordinated hindlimb movements earlier than controls and demonstrated consistent coordination from 4 to 6 weeks. Vehicle-treated rats showed only modest improvements in hindlimb function. The amount of spared tissue was significantly higher in bFGF-treated rats than in controls. Astrocyte and microglial reactivity was more pronounced in bFGF-treated animals versus controls. In summary, intrathecal infusion of exogenous bFGF following SCI significantly reduces tissue damage and enhances functional recovery. Early pharmacological intervention with bFGF following SCI may serve a neuroprotective role and/or create a proregenerative environment, possibly by modulating the neuroglial response.

AB - The rapid increase in basic fibroblast growth factor (bFGF) production following spinal cord injury (SCI) in rats is thought to serve a role in the cellular processes responsible for the functional recovery often observed. In this study, bFGF was intrathecally administered continuously for I week beginning 30 min after a moderate (12.5 mm) spinal cord contusion in adult rats using the New York University impactor device. Osmotic minipumps were implanted into the lateral ventricle and lumbar thecal sac to deliver bFGF at a rate of 3 μg or 6 μg per day versus control vehicle. Animals were behaviorally tested for 6 weeks using the Basso, Beattie, Bresnahan locomotor rating scale and histologically assessed for both tissue sparing and glial reactivity rostral and caudal to the lesion. Rats treated with bFGF regained coordinated hindlimb movements earlier than controls and demonstrated consistent coordination from 4 to 6 weeks. Vehicle-treated rats showed only modest improvements in hindlimb function. The amount of spared tissue was significantly higher in bFGF-treated rats than in controls. Astrocyte and microglial reactivity was more pronounced in bFGF-treated animals versus controls. In summary, intrathecal infusion of exogenous bFGF following SCI significantly reduces tissue damage and enhances functional recovery. Early pharmacological intervention with bFGF following SCI may serve a neuroprotective role and/or create a proregenerative environment, possibly by modulating the neuroglial response.

KW - Astrocytes

KW - Behavior

KW - GFAP

KW - Microglia

KW - OX-42

KW - Tissue sparing

KW - White matter

UR - http://www.scopus.com/inward/record.url?scp=0032833031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032833031&partnerID=8YFLogxK

M3 - Article

C2 - 10521141

AN - SCOPUS:0032833031

VL - 16

SP - 817

EP - 830

JO - Journal of Neurotrauma

JF - Journal of Neurotrauma

SN - 0897-7151

IS - 9

ER -